Mianserin hydrochloride |
21535-47-7 |
Mianserin HCl |
Mianserine hydrochloride |
Tolvon |
ORG GB 94 |
Mianserin (hydrochloride) |
Lerivon |
mianserine HCl |
1,2,3,4,10,14b-Hexahydro-2-methyldibenzoc,fpyrazino1,2-aazepine hydrochloride |
MLS000069681 |
2-methyl-1,2,3,4,10,14b-hexahydrodibenzoc,fpyrazino1,2-aazepine hydrochloride |
Athymil |
ORG GB-94 HCl |
SMR000058472 |
Bolvidon |
MFCD00055072 |
Tolvin |
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine hydrochloride |
CHEBI:31843 |
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)-pyrazino(1,2-a)azepine monohydrochloride |
Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, monohydrochloride |
SR-01000000185 |
C18H20N2.HCl |
GB 94 |
Tetramide (TN) |
Prestwick_514 |
EINECS 244-426-7 |
Mianserin hydrochloride USAN:JAN |
(.+-.)-Athymil |
Opera_ID_1505 |
(.+-.)-Norval |
cid_68551 |
MLS001148213 |
MLS002222220 |
SCHEMBL340474 |
SPECTRUM2300292 |
CHEMBL544428 |
Mianserin hydrochloride solution |
BDBM31005 |
HY-B0188A |
DTXSID30944145 |
HMS1568C20 |
Pharmakon1600-02300292 |
BCP09259 |
EBD23593 |
Mianserin hydrochloride (JAN/USAN) |
Tox21_500744 |
CCG-39108 |
NSC292267 |
NSC759590 |
s1382 |
AKOS015902308 |
CS-2079 |
KS-5096 |
LP00744 |
NSC 759590 |
NSC-292267 |
NSC-759590 |
VA11292 |
NCGC00094086-01 |
NCGC00094086-02 |
NCGC00094086-03 |
NCGC00094086-04 |
NCGC00261429-01 |
AC-25005 |
BM166416 |
AB0008516 |
DB-045611 |
EU-0100744 |
M2623 |
SW196707-3 |
C74052 |
D01358 |
M 2525 |
535M477 |
A912434 |
SR-01000000185-2 |
SR-01000000185-4 |
SR-01000000185-8 |
W-111733 |
Q27114695 |
Mianserin Hydrochloride 1.0 mg/ml in Methanol (as free base) |
Mianserin hydrochloride, analytical standard, for drug analysis |
Mianserin hydrochloride, European Pharmacopoeia (EP) Reference Standard |
1,2,3,4,10,14b-Hexahydro-2-methyl-dibenzoc,fpyrazino1,2-aazepine hydrochloride |
1,2,3,4,10,14b-Hexahydro-2-methyldi benzoc,fpyrazino1,2-aazepine hydrochloride |
1,2,3,4,10,14b-Hexahydro-2-methyldibenzoc,fpyryzino1,2-aazepine hydrochloride |
Mianserin for system suitability, European Pharmacopoeia (EP) Reference Standard |
5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7.0^{8,13nonadeca-1(19),8,10,12,15,17-hexaene;hydrochloride |
5-methyl-2,5-diazatetracyclo13.4.0.02,7.08,13nonadeca-1(19),8,10,12,15,17-hexaene;hydrochloride |
78644-54-9 |
Bolvidon; 1,2,3,4,10,14b-Hexahydro-2-methyl-dibenzoc,fpyrazino1,2-aazepine hydrochloride |
Hydron;5-methyl-2,5-diazatetracyclo13.4.0.02,7.08,13nonadeca-1(19),8,10,12,15,17-hexaene;chloride |
Mianserin hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material |
|